Imaging and Biological Markers for Prediction and Identification of Glioblastoma Pseudoprogression: a Prospective Study.

PET examination of glioblastoma using 18F-GE-180 PET radio-metabolic marker

MRI examination using advanced sequences to characterize tumor microstructure and function

Hematopoietic stem cells will be collected by the aspiration of bone marrow during the surgical intervention for tumor resection

blood withdrawal for evaluation of plasma biomarkers of inflammation, circulating microvesicles, and RNA

Glioblastoma stem cells (GSCs) will be isolated from the tumor